Saturday, July 11, 2026

pharma · Henoch-Schoenlein Purpura Nephritis

Nanjing Children's Hospital

Nanjing Children's Hospital clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Nanjing Children's Hospital projects

1 ClinicalTrials.gov programs sponsored by Nanjing Children's Hospital.

Nanjing Children's Hospital has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Prednisone

    Nanjing Children's Hospital

    Henoch-Schoenlein Purpura Nephritis

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Nanjing Children's Hospital have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.